SAAL1, a novel oncogene, is associated with prognosis and immunotherapy in multiple types of cancer
Abstract Serum amyloid A-like 1 (SAAL1) was recently identified as a novel oncogene in hepatocellular carcinoma (HCC). To explore the…
Abstract Serum amyloid A-like 1 (SAAL1) was recently identified as a novel oncogene in hepatocellular carcinoma (HCC). To explore the…